Observational study on the treatment of patients with metastatic breast cancer

Trial Identifier:	D9673R00053
Sponsor:	AstraZeneca
Start Date:	November 2024
Primary Completion Date:	November 2025
Study Completion Date:	November 2025
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil	Fortaleza, Brazil
Brazil	Porto Alegre, Brazil
Brazil	Salvador, Brazil
Brazil	São Paulo, Brazil

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.